selected publications
- Editorial: Thymus biology: development, immunodeficiency and cancer progression. Frontiers in immunology. 2026 Editorial Article GET IT
- Longitudinal genomic analysis of five cases of recurrent thymomas. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2025 Academic Article GET IT
-
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy.
Nature immunology.
2024
Academic Article
GET IT
Times cited: 2 - Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockade. 2023 GET IT
-
Current knowledge of small cell lung cancer transformation from non-small cell lung cancer.
Seminars in cancer biology.
2023
Review
GET IT
Times cited: 38 - Reply to Dr. Goto's Letter: "A Thymoma Mouse Model Harboring a Gtf2i L424H Mutation". Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2022 Letter GET IT
- A Knock-in Mouse Model of Thymoma with the GTF2I L424H Mutation. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2022 Academic Article GET IT
-
Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trials.
Expert opinion on investigational drugs.
2022
Review
GET IT
Times cited: 10 - The regulation of CD73 in non-small cell lung cancer. European journal of cancer. 2022 Academic Article GET IT
-
Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansine.
British journal of cancer.
2021
Academic Article
GET IT
Times cited: 6 -
Molecular predictors of response to pembrolizumab in thymic carcinoma.
Cell reports. Medicine.
2021
Academic Article
GET IT
Times cited: 48 -
Arginase Pathway Markers of Immune-Microenvironment in Thymic Epithelial Tumors and Small Cell Lung Cancer.
Clinical lung cancer.
2021
Academic Article
GET IT
Times cited: 2 -
Downregulation of CYLD promotes IFN-γ mediated PD-L1 expression in thymic epithelial tumors.
Lung cancer (Amsterdam, Netherlands).
2020
Academic Article
GET IT
Times cited: 18 -
Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis.
Oncogene.
2020
Academic Article
GET IT
Times cited: 14 -
Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate.
Oncogene.
2019
Academic Article
GET IT
Times cited: 8 -
Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells.
Oncogene.
2018
Academic Article
GET IT
Times cited: 15 -
An Indispensable Role of Androgen Receptor in Wnt Responsive Cells During Prostate Development, Maturation, and Regeneration.
Stem cells (Dayton, Ohio).
2018
Academic Article
GET IT
Times cited: 15